CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT AND CEO sold 12,500 shares at an average $22.18 ($277,292)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,000 shares at $22.55 ($67,655)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- S-3MEF Other S-3MEF
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale CHIEF OPERATING OFFICER sold 6,667 shares at an average $20.34 ($135,574)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 7,500 shares at $20.03 ($150,220)
- 4 Planned sale PRESIDENT AND CEO sold 7,500 shares at $20.05 ($150,352)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $16.18 ($52,593)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 5,000 shares at $16.31 ($81,534)
Page 10 of 40 · 798 filings